Announcements

Cellistic reveals groundbreaking iPSC-based platforms to accelerate off-the-shelf allogeneic cell therapy development and manufacturing

October 9, 2023

Cellistic reveals groundbreaking iPSC-based platforms to accelerate ...

Mont-Saint-Guibert, Belgium

Ncardia And Cellistic Recruit Charles Jacques as new Chief Financial Officer

August 15, 2023

Ncardia And Cellistic Recruit Charles Jacques as new Chief Financial ...

Leiden, Netherlands and Mont-Saint-Guibert, Belgium (August 15, 2023) – Ncardia and Cellistic ...

The next milestone in allogeneic cell therapy development: FDA approval for allogeneic type 1 diabetes treatment

June 30, 2023

The next milestone in allogeneic cell therapy development: FDA approval ...

The U.S. Food and Drug Administration (FDA) has recently granted approval to Lantidra, an ...

Revolutionizing Cancer Treatment: FDA recently approved an allogeneic CAR-T Therapy

February 9, 2023

Revolutionizing Cancer Treatment: FDA recently approved an allogeneic ...

Autologous CAR-T cell therapy has revolutionized the way some cancers are treated, offering ...

Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses through their next phase of growth

January 5, 2023

Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses ...

– Gustavo Mahler hired as the Chief Executive Officer of Ncardia and Cellistic, and will join ...

Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations Transaction

September 20, 2022

Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing ...

← 1 2 3 →